• by bcarlson@marketresearch.com
  • December 30 2014


Opportunity in Prenatal Segment For Emerging Test Products

Opportunity in Prenatal Segment For Emerging Test Products

Kalorama Information has reported extensively on prenatal testing markets for more than a decade, but the recently there’s been an increase in opportunity, as revealed in our latest study of Women’s Health Diagnostics Markets. Family planning and coordination of care for a child born with health conditions are increasingly relevant issues for the in vitro diagnostics (IVD) community that is increasingly involved in the prenatal testing market. While ethical considerations will arise with further...

  • by bcarlson@marketresearch.com
  • December 22 2014
  • CT systems


Low Dose Concerns Drive CT System Sales: DotMed Article Featuring Kalorama Analysis

Low Dose Concerns Drive CT System Sales: DotMed Article Featuring Kalorama Analysis

New regulations and innovation will drive sales of CT systems. XR-29 regulations that involve low-dose mandates will help convince on the fence customers to purchase new systesm. Kalorama feels the low-dose concerns have already been a factor for everyone involved in CT. Recent article on CT systems in medical device magazine DotMed features commentary from Kalorama Information. Article:http://www.dotmed.com/news/story/24837



Low-dose has been a concern for several years now but the impending...


Eurofins Acquisitions Highlight Leading Growth Areas in Clinical Laboratory Services Market

Eurofins Acquisitions Highlight Leading Growth Areas in Clinical Laboratory Services Market

Eurofins Scientific, a leading global provider of “bioanalytical” laboratory testing services with projected 2014 revenue of approximately $1.7 billion , recently broadened its business activities into the clinical space with two acquisitions. The laboratory group’s traditional business activities are overwhelmingly within food and feed testing (~40% of revenue); pharmaceutical and biotechnology industry testing (40%); and environmental testing (20%). Eurofins already serves as a contract resear...


Rising Diagnostics Standards Drive Growth in Women’s Health Market

Rising Diagnostics Standards Drive Growth in Women’s Health Market

Once limited to obstetrics and gynecology, women’s health now encompasses the fields of urology, maternal-fetal medicine, oncology, and even autoimmune diseases such as cystic fibrosis. In recent years, specialty diagnostics have in part driven exceptional growth in women’s health compared to the overall markets for in vivo (medical imaging) and in vitro (lab testing) diagnostics. Continued penetration and standardization of several diagnostic procedures are expected to lead market growth for wo...

  • by bcarlson@marketresearch.com
  • December 2 2014


Demand Surges for Biologics Production As Capacity Nears Limit

Demand Surges for Biologics Production As Capacity Nears Limit

The biopharmaceutical and vaccine production market is estimated to reach $41 billion in 2014, according to our recent report on the industry. Firms are near capacity with the amount of biologic development. It is estimated there are more than 400 biotech drug products and vaccines targeting hundreds of the diseases in the pipeline. Over the next several years, as the number of biologics produced increases, the demand for biologic manufacturing capacity will continue to increase.

Demand contin...